| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Olaptesed Pegol | NOX-A12 | Phase 2 Clinical | Noxxon Pharma | Colorectal Neoplasms; Glioblastoma; Hematopoietic stem cell transplantation (HSCT); Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Pancreatic Neoplasms | Details |
| PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Carcinoma, Hepatocellular | Details |
| JVS-100 | JVS-100; SRX-100; ACRX-100; GP-51801; GP51801 | Phase 1 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Peripheral Arterial Disease; Surgical Wound | Details |
| CK-0804 | CK-08041; CK-0804 | Phase 1 Clinical | Cellenkos Inc | Primary Myelofibrosis | Details |
| MyoCell SDF-1 | MyoCell SDF-1 | Clinical | U.S. Stem Cell | Heart Failure | Details |